Market Overview

UPDATE: Buckingham Research Doubts J.C. Penney Credibility and Recovery

Related JCP
No Legwork Wednesday – J.C. Penney And The 'No Sale' Debacle
Top 4 NYSE Stocks In The Department Stores Industry With The Highest Revenue
Citi Boosts J.C. Penney to 'Buy' from 'Neutral' (Fox Business)

In a report published Friday, Buckingham Research Group analyst David Glick downgraded J.C. Penney Co. (NYSE: JCP) from Buy to Neutral and significantly lowered the PT from $20 to $10.

Yesterday, JCP announced Goldman Sachs is underwriting their public equity offering for 84M shares. Initial offering was priced at $9.65 a share, approximately $811M (before fees) and 40% dilution for existing shareholders. Glick noted, β€œThe underlying reasons for this sudden need for expensive capital, the damage to JCP's credibility, and the more challenging than expected consumer environment all pose threats to the pace of JCP's recovery.”

Buckingham Research Group reported their doubts of management's credibility, JCP's overall recovery, operating projections, and stability during the holiday period. Further, the analyst is concerned with the repercussion of the earlier public announcement where JCP commented that they do not need to raise capital.

Glick forecasted FY13 EBITDA estimates of $604M and FY14 EBITDA estimates of $163M.

JCP closed at $10.42 on Thursday.

Posted-In: Buckingham Research David GlickAnalyst Color Downgrades Analyst Ratings

 

Most Popular

Related Articles (JCP)

Around the Web, We're Loving...

Partner Network

Get Benzinga's News Delivered Free